NCT00000421View on ClinicalTrials.gov

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2003

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Prednisone

DRUG

Placebo

Trial Locations (3)

10002

Lenox Hill Hospital, New York

10461

Office of Betty Diamond, M.D., The Bronx

11040

North Shore-Long Island Jewish Health System, New Hyde Park

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

NYU Langone Health

OTHER

NCT00000421 - Serologically Active, Clinically Stable Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter